PHARM Flashcards

1
Q

What is KD?

A

Dissociation constant, concentration at which 50% receptors bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Emax and EC50

A

Max- Measure of efficacy, maximum response at peak
50- Measure of potency, concentration to create 50% of max response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many receptors are occupied in a maximum response for full agonists and partial agonists?

A

Full- not all
Partial- all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does competitive surmountable antagonists alter agonist response?

A

Efficacy unchanged, potency reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What areas and affect do a and b adrenoreceptors have?

A

a1- constricts blood vessels, dilates pupil, constricts GIT
a2- inhibit transmitter release in nerves
b1- increase rate and force of heart, renin secretion in kidney
b2- skeletal muscle contractility, dilate bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 areas where non-competitive inhibition can occur?

A
  1. Chemical antagonism to chemically inactive, drugs or antibodies
  2. Allosteric modulation
  3. Pathway inhibition, multiple potential targets
  4. Functional antagonism, two agonists with opposite effects e.g. Na and Ach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is bioavailability?

A

Proportion of administered drug that reaches circulation e.g prodrug that is metabolizes would have low, intravenous would have high

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is first pass metabolism?

A

Passing through liver to reach circulation, can be metabolized and form active molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is volume of distribution?

A

The amount of drug in body divided by the concentration in plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the lengths of PS and S pre-ganglionic neurons?

A

PS long close to site of action
S short, to sympathetic chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the neurotransmitters and receptors involved in somatic, PS, sympathetic for muscle organs, sympathetic for sweat glands and sympathetic for adrenal glands?

A

Somatic- No postganglionic, ACh to nicotinic (nAChR)
PS- ACh to nAChR on postganglionic (same for all postganglionic), ACh to muscarinic (mAChR)
S, muscle/organs- ACh to nAChR on postganglionic, noradrenaline to ab adrenoreceptors
S, sweat- ACh to nAChR on postganglionic, ACh to mAChR
S adrenal- ACh to nAChR on postganglionic, Adrenaline to circulation and ab adrenoreceptors in tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the steps of chemical transmission?

A
  1. AP, membrane depolarisation
  2. Synthesis
  3. Storage
  4. Ca2+ dependent vesicular exocytosis
  5. Receptor activation
  6. Reuptake
  7. Degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can catecholamine production be altered (3)?

A
  • L-DOPA, product of rate limiting stepped, increases NA/A
  • Carbidopa, DOPA decarboxylase inhibitor which turns L-DOPA to dopamine
  • VMAT inhibitor (e.g. reserpine), inhibits dopamine uptake into vesicles by VMAT where dopamine is converted to noradrenaline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the primary and secondary reuptake process?

A

Primary: NET into neuron
Secondary: OCT3 extraneuronally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What metabolizes noradrenaline at the nerve terminal?

A

Monoamine oxidase (MAO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What drugs interfere with the reuptake process (3)?

A
  • Tricyclic Antidepressants (TCA’s) inhibit NET, prevent reuptake, longer presence in junction and increased binding
  • MAO inhibitors, noradrenaline not metabolized, more can enter vesicles
  • Indirectly-acting Sympathomimetics (IAC’s) e.g. ephedrine, similar structure to NA, uptake by NET, displace NA in vesicles, NA can exit neurons via NET and have bind in junction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can acetylcholine synthesis and storage be inhibited (3)?

A
  • Hemicholinium (experimental) blocks high affinity choline transporters (rate limiting step), which will transport choline (ACh precursor) into the neuron
  • Vesamicol (experimental) blocks vesicular acetylcholine transporter from transporting ACh into the vesicle to be released into the junction
  • Botulinum Toxin, heavy chain binds irreversibly to receptors for neurons containing ACh, endocystosed, light chain cleaves SNARE proteins, SNARE complex cannot form and vesicle and membrane cannot fuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the symptoms of Botulinum poisoning?

A

Facial weakness, difficulty swallowing, limb paralysis, anti-SLUD (salivation, lacrimation, urination, defecation) dry mouth, dry eyes, urinary retention, constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What drugs interfere with cholinergic metabolism at neuromuscular junction (3)?

A
  • Anticholinesterases prevent acetylcholinesterases from metabolizing ACh into choline
  • d-Tubocurarine, competitive reversible antagonist of nAChR postjunction, allows skeletal m. relaxation during surgery
  • Suxamethonium, nAChR agonist, causes prolonged depolarization, muscle relaxes as it cannot undergo repolarization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is Myasthenia Gravis and how is it treated?

A

Muscle weakness caused by auto-antibodies degrading nAChRs meaning ACh is degraded before getting a big enough response. Eye movement, swallowing, facial expression first effected then limbs.

Neostigme is a reversible anti-cholinesterase specific for neuromuscular junction. Prevents ACh metabolism, bigger response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Muscarinic Effects, SLUDGE, DUMBBELS

A

Salivation, Lacrimation, Urination, Diarrhea, GIT upset, Emesis (vomiting)

Diarrhea/Diaphoresis (sweating), Urination, Miosis (pupil contracted), Bradycardia/Bronchospasm, Emesis/excitation, Lacrimation/Lethargy, Salivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Where are M2 and M3 receptors found?

A

M2- heart
M3- glandular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are N1 and N2 receptors?

A

N1- neuromuscular junction
N2- autonomic ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are high nicotinic and muscarinic agonists?

A

Nicotinic- Acetylcholine, Carbachol, Nicotine
Muscarinic- Acetylcholine, Methacholine, Bethanechol, Muscarine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is atropine?

A

Muscarinic antagonist, stops secretions (DUMBBELS) during surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are some modifiable and non-modifiable risk factors for CVD?

A

Non-mod- age, sex, ethnicity, family history
Mod- diet, exercise, substance abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Function of CVD?

A

DR MED
Distribute hormones, essential substances, heat
Remove metabolic by-products
Mediate inflammatory factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What factors affect cardiac output?

A

Stroke volume, volume ejected per beat
Heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do adrenergic and cholinergic receptors affect heart rate?

A

ACh -> M2, decrease
Adrenaline/Noradrenaline -> B1, increase

30
Q

What is preload and how does it influence stroke volume?

A

Load placed on muscle before contraction, greater muscle length -> greater force of contraction

31
Q

What is contractility and how do adrenergic and cholinergic receptors affect it?

A

Strength of contraction, A/NA -> B1

32
Q

What factors affect stroke volume?

A

Contractility, preload and afterload (resistance to outflow from left ventricle)

33
Q

How does B1 activation affect preload?

A

B1 activation causes renin release which increases blood volume and thus preload

34
Q

What is the ABCD?

A

ACE inhibitors
Beta blockers
Calcium Antagonists
Diuretics

35
Q

What is the action of beta blockers?

A

Inhibit activation of cardiac B1 receptors, decrease cardiac output

Inhibit activation of renal B1 receptors, decrease renin secretion, H2O retention and thus preload

36
Q

What are some AE’s of beta blockers

A

Reduced exercise capacity, muscle fatigue, bronchoconstriction

36
Q

What is the action of diuretics?

A

Increase secretion of Na+, water follows resulting in decreased blood volume and pressure

37
Q

What is the action of thiazide diuretics?

A

Inhibits Na-Cl cotransporter to increase Na+ excretion

38
Q

What are some AE’s of thiazide diuretics?

A

Hypokalemia (decreased blood K+), uric acid retention, impaired glucose tolerance.

39
Q

What is the results of angiotensin II (3)?

A
  • Cardiovascular remodelling (hypertrophy and vascular redistribution of mass)
  • Vasoconstriction, increasing TPR and blood pressure
  • Aldosterone secretion, increase Na+/H2O retention, increase BP
40
Q

What is the action of ACE inhibitors?

A

Inhibit ACE, the enzyme that converts Angiotensin I to Angiotensin II, decreases BP. Also decreases BP as ACE breaks down bradykinin into inactive metabolites, a build up of bradykinin causes vasodilation and decreased BP

41
Q

How are AT1R antagonists different to ACE inhibitors?

A

AT1R antagonists prevent binding of angiotensin II at At1R receptors that normally cause vasodilation and aldosterone secretion. It also prevents the dry cough that can occur due to bradykinin build up during ACE inhibition.

42
Q

What are some RAAS inhibitor AEs

A

1st dose hypotension (excessive BP fall), hyperkalemia (aldosterone also secretes K+ into urine) and acute renal failure

43
Q

What is the action of Calcium Channel Blockers?

A

No Ca2+ enters the cell, no smooth muscle contraction, increased BP

44
Q

What are the three classes of CCBs and effective sites of action?

A

Dihydropyridines e.g. nifedipine
Benzothiazepines e.g. diltiazem
Phenylakylamines e.g.verapamil

Arterial smooth m. Nifedipine&raquo_space; Verapamil > Diltiazem
Myocardium/non-conducting tissue Verapamil > Diltiazem&raquo_space; Nifedipine

45
Q

What are AEs for each class and general AEs?

A

Nifedipine- reflex tachycardia, palpitations, nausea, headaches
Diltiazem- bradycardia, AV block
Verapamil- “ “
General- Reflex tachycardia, flushing, headache

46
Q

What are the steps before pharamacotherapy for regulation of serum lipids?

A

Establish fasting blood lipid profile
Cardiovascular risk
Treat secondary cause of dyslipidaemia
Manage modifiable risk factors

47
Q

What is the action of statins?

A

Resembles HMG-CoA, precursor for HMG-CoA reductase (rate limiting step), decreases cholesterol synthesis

48
Q

What are the AEs of statins?

A

mild GI symptoms, headache, insomnia, dizziness

49
Q

What is the action of bile sequestrants/resins?

A

Bind negatively charged bile acids, inhibit reabsorption, excretion

50
Q

What are the AEs of bile sequestrants/resins?

A

Abdominal discomfort, bloating, constipation, flatulence

51
Q

What is the action of ezetimibe?

A

Binds to NPC1L1 transporter preventing cholesterol absorption and lowering LDL

52
Q

What are the AEs of ezetimibe?

A

Diarrhea, headache, tiredness, stomach pain

53
Q

What is the action of nicotinic acid/niacin?

A

Lowers secretion of VLDL from liver, lowers LDL and triglycerides, increases HDL

54
Q

What are the AEs of nicotinic acid/niacin?

A

Flushing, nausea,

55
Q

What is the action of PCSK9 monoclonal antibodies (e.g.evolovumab)?

A

Prevent PCSK9 from binding to LDL bound receptors and initiating endocytosis

56
Q

What are the AEs of PCSK9 monoclonal antibodies (e.g.evolovumab)?

A

Headache, nausea, diarrhea

57
Q

What are the drugs for treatment of hypercholesterolaemia?

A

SPENB
Statins, PCSK 9 inhibitors, Ezetimibe, Niacin, Bile acid resins

58
Q

What is the action of fibrates?

A

Alter the gene expression, increase lipolysis, moderate decrease in triglycerides, moderate increase in HDL

59
Q

What do fish oils do?

A

Omega 3 fatty acids, decreases VLDL and therefore circulating trigylcerides

60
Q

What are the four classes and an example of heart rate drugs?

A

Na+ channel block, Lignocaine
B-adrenoreceptor antagonism, Propranolol
K+ channel block, Amiodarone
Ca2+ channel block, Verapamil

61
Q

What is the action and AEs of Na+ channel blockers?

A

Slow phase 0 of ventricular action potential, decrease excitability and conduction of heart
Light headedness, muscular twitching, lip/tongue numbness

62
Q

What is the action and AEs of K+ channel blockers?

A

Prolongs ventricular action potential, slowing of phase 3 repolarization

Skin discoloration, hypothyroidism

63
Q

What is the action and AEs of Ca+ channel blockers?

A

Inhibit calcium influx that contributes to increased contractility and rate

Oedema, flushing, headache

64
Q

What is the action of Digoxin?

A

Inhibit Na/K ATPase, Ca2+ remains in sarcoplasmic reticulum, increased contractility, slows rates

65
Q

What unclassified agents increase rate?

A

Atropine, adenosine

66
Q

What is the action of nitrates NO in angina and an example?

A

Relaxation of vessels, decrease preload
Glyceryl trinitrate, 1st pass metabolism

67
Q

What are AEs of nitrates?

A

Headache, flushing, reflex tachycardia

68
Q

What are AEs of beta blockers?

A

Fatigue, bradycardia, bronchoconstriction

69
Q

What is the action of Ivabradine?

A

Inhibition of inward Na-K current in sinus node, decreases diastolic depolarization, pure heart rate reduction

70
Q

What are the AEs of Ivabradine?

A

Bradycardia, blurred vision

71
Q
A